Zusammenfassung
Häufigkeit: Ein Phäochromozytom ist in 0,1% der Fälle Ursache eines Hypertonus. Autopsieergebnisse legen aber nahe, daß die wirkliche Prävalenz wahrscheinlich höher ist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Averbuch ASD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine and dacarbazine. Ann Intern Med 109: 267–273
Bravo EL (1991) Diagnosis of pheochromocytoma: Reflections on a controversy. Hypertension 17: 742–744
Brodgen RN, Heel RC, Speight TM,. Avery GS (1981) Alpha-methyl-parathyrosine: A review of its pharmacology and clinical use. Drugs 21:81–89
Hauptmann JB, Modlinger RS, Ertel NH (1983) Pheochromocytoma resistent to alpha-adrenergic blockade. Arch Intern Med 143:2321–2323
Hofstra RMW, Landsvater RM, Ceccherini I et al. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia typ 2B and sporadic medullary thyroid carcinoma. Nature 367: 375–376
Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED (1987) Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 13: 793–797
Krempf M, Lumbroso J, Mornex R et al. (1991) Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 72: 455–461
Landsberg L, Young JB (1992) Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW (eds) Williams textbook of endocrinology, 8nd edn. Saunders, Philadelphia, pp 621–705
Lehnert H, Dörr H.-G, Ziegler R (1993) Nebennierenmark. In: Ziegler R, Pickardt CR, Willig R.-P. (eds) Rationelle Diagnostik in der Endokrinologie einschließlich Diabetologie and Stoffwechsel. Thieme, Stuttgart New York, S 167–185
Lips CJ, Landsvater RM, Höppener JWM, Geerdink RA, Blijham G, van Veen JM, van Gils AP, de Wit MJ, Zewald RA, Berends MJ et al. (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A [see comments]. N Engl J Med 331: 828–835
Löhrs U (1987) Morphologische und immunhistochemische Befunde bei malignen endokrinen Tumoren. In: Engelhardt D, Mann K (eds) Endokrin-aktive maligne Tumoren. Springer, Berlin Heidelberg New York Tokyo, S 1–10
Mathew CGP, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BAJ (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328: 525–526
Mattrey RF, DeRoo TR (1992) Magnetic resonance Imaging of the endocrine glands: Thyroid, parathyroid, and adrenal. In: Wilson JD, Bagdade JD (editorin-chief) Year book of endocrinology. Mosby Year Book, St. Louis/MO, pp XXI-XXXIV
Reubi JC, Waser B, Khosla S et al. (1992) In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 74: 1082–1089
Sailer B, Jacob K, Markl A, Zwiebel FM, Engelhardt D, Mann K (1989) Rezidivierende Hochdruckkrisen und Dyspnoe nach einseitiger Adrenalektomie wegen Phäochromozytom bei einer 44jährigen Patientin. Internist 31: 78–81
Schuppert F, Scheumann G, Schöber C et al. (1991) Therapie eines malignen sympathischen Paraganglioms des Zuckerkandlschen Organs–ein Fallbericht. Klin Wochenschr 69: 937–942
Schürmeyer TH, Dralle H, Schuppert F, von zur Mühlen A (1988) Präoperative Diagnostik bei Verdacht auf Phäochromozytom-retrospektive Beurteilung diagnostischer Kriterien. Acta Med Austriaca 4: 106
Serri O, Comtois R, Bettez P, Dubuc P, Buu NT, Kuchel O (1984) Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy. N Engl J Med 310: 1264–1265
Sheps SG, Jiang NS, Klee GG, Van Heerden JA (1990) Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 65: 88–95
Sisson J, Frager MS, Valk TW et al. (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305: 12–17
Takeda M, Katagiri A, Kanai T et al. (1991) Treatment of malignant pehochromocytoma by combination of CVD regimen and transarterial embolization. Nippon Hinyokika Gakkai Zasshi 82: 826–829
Tippett PA, McEwan AJ, Ackery DM (1986) A re-evaluation of dopamine excretion in pheochromocytoma. Clin Endocrinol 25: 401–410
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schuppert, E., Schmoll, HJ. (1997). Phäochromozytom und Paragangliom. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_43
Download citation
DOI: https://doi.org/10.1007/978-3-662-12175-7_43
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60830-1
Online ISBN: 978-3-662-12175-7
eBook Packages: Springer Book Archive